NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis.
Dinkin
Marc J
MJ
Department of Neurology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA. mdinkin@partners.org
Cestari
Dean M
DM
Stein
Marion C
MC
Brass
Steve D
SD
Lessell
Simmons
S
D000328:Adult; D051401:Aquaporin 4 / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D001921:Brain / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D009188:Myelitis, Transverse / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D009902:Optic Neuritis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D012008:Recurrence
C496030:AQP4 protein, human; D051401:Aquaporin 4; D001323:Autoantibodies; D001324:Autoantigens; D005938:Glucocorticoids; D007074:Immunoglobulin G; D008776:Methylprednisolone Hemisuccinate